Although he only left a 10% share of the shares, the benefits represented by this achievement are extremely amazing compared to the astronomical wealth that the new anticancer drugs will create in the future.

Switching to other people, or disagree, the drug was stuck by the Food and Drug Administration, and it was too late to pass the review. Billions of research and development funds were spent, and the cost of a penny could not be recovered, or it would be great. Some of the interests have been handed over, retaining that 10% of the shares is enough for him to earn a pot full, I believe most people will choose to surrender in the face of this situation!

However, this naturally does not include Chen Mo, let alone 90%, Chen Molian's 1% of the shares will not let out!

Play with me, you are looking for the wrong object!

Just now, the other party’s telephone content, Chen Moquan, clearly heard that the president of the Merck Medical Group did not say a threat, but combined with the fact that their drug review was just stuck by the Food and Drug Administration, the call was made. In fact, it is threatening!

Either cooperate and give up most of the benefits, or you will be completely stuck, and you won’t be able to get a penny!

The other party can make the Food and Drug Administration face and catch them, which is enough to show that they have the strong strength, they naturally have the confidence to respond to the Aegis creatures.

The Food and Drug Administration has not violated any regulations. It is just doing things according to the rules. At most, they can say that they are a little bit rigid, and the starting point is for drug safety!

Even if it is in the media, it will not affect them. They still need to conduct long-term clinical trials according to regulations, and then wait for further review.

At that time, they can continue to delay for various reasons. As long as Chen Mo does not compromise, Aegis will be completely killed!

Chen Mo is almost certain that this thing is probably not just a simple pharmaceutical company of Merck Pharmaceutical Group!

But will Chen Mo be threatened?

This may be the only place they have missed!

“To send people to contact the health departments of China, Europe and other countries, we said that we intend to open branches in their countries, establish pharmaceutical factories, and take this new anticancer drug into the market in their country!”

Chen Mo said calmly.

Su Shi heard the words in front of her eyes, she did not expect it!

The new drugs developed by general pharmaceutical companies will pass the examination in the country and then enter other countries. The process of re-examination will be much simpler. Almost no one will go far and go to other countries for the initial review of drugs.

However, this is a good way for them. Since the Food and Drug Administration of the country has stuck their new anti-cancer drugs, they can go to other countries for review, even if the country does not recognize other countries. The result of the audit, the big deal is to give up the rice market, the world is so big, and it’s not that you can’t live without the rice country!

After their new anti-cancer drugs are first listed in other countries, and after seeing the actual results, I don’t know if the officials of these food and drug administrations will be drowned by the mouth of the people of the country!

As for the people of the country, there is no way to receive treatment. Don't forget, Su Shi and Chen Moke are both Chinese!

There are good things to be naturally close to your own compatriots. Officials of your own country are dead, and we have no choice!

The previous review in the country was only for convenience. When the review was passed, both Su Shi and Chen Mo would not forget their Chinese compatriots, and they will inevitably put the drug into the Chinese market at the same time.

In the current situation, they need to re-examine in various countries. Although it may lead to the delay of listing of drugs, China is inevitably their primary goal. As for the rice countries that could be the first beneficiary countries together with China, it is likely to become the world. The last country to launch new anticancer drugs!

Su Shidang, who is suddenly open-minded, even began to contact the health departments of China and Europe to express his willingness to open branches and conduct drug audits in various countries.

Countries received news, they were very pleasantly surprised, yes, it was a surprise!

The new anti-cancer drugs of Aegis have been reported by the major media in the country before, and have been known to all countries in the world. For the drugs that may completely cure cancer, the health departments of all countries attach great importance to them, and they also send people to this kind of The clinical trials of new anticancer drugs have been investigated and found that the media is not exaggerated, and Aegis has no fraud.

Comparing the results of the analysis of the disease before and after the cancer patients, the effect of the drug is clear at a glance, and indeed inhibits the proliferation and spread of cancer cells. All the patients participating in the trial have a great improvement in their condition, which is the case for most of these cancers. A patient who may die at any time is unthinkable!

However, according to normal circumstances, this drug will inevitably be approved by the country in the country to obtain a license, and then put on the world market. They only want to contact Aegis Technology to introduce the drug into the country after the drug has passed the review. .

As for allowing Aegis to go to their country for drug review, there has never been such a precedent.

This is like taking a driver's license. Whoever drives a driver's license in his hometown or at a school or company location will drive to the field. Who will go farther and go farther to test the driver's license.

But now Aegis is doing this!

So after receiving the request for the construction of a branch and drug review in the country, lightnovelpub.net~ countries are all pleasantly surprised, because it means that this new anticancer drug will be the first in their country. use!

Moreover, Aegis is not just setting up a branch, but also building factories in various countries, which means that the drug will be imported from domestic to domestic, avoiding high import and export tariffs, and the final price will be much cheaper. !

In addition to the tangible benefits of cancer patients in the country, this is also a huge achievement for them!

They have no reason to refuse, but they are all enthusiastic and come up with various preferential policies. I hope that Aegis can set up factories and put them on the market in their country.

Other countries that have not been contacted by Su Shi, such as India, Japan, Australia and other countries, have also taken the initiative to contact Aegis, and have sent invitations, hope that Aegis can establish a branch in their country and promise Simplify the drug review process.

However, in fact, this kind of review does not need to be carried out once in every country. As long as one country issues a drug license, the review in other countries will be much more convenient.